Home » Topics » BioWorld

BioWorld
RSS

NPS Completes $4 Million Financing

July 17, 1992

WERTHEIM TAGS IMMUNEX A 'BUY'

July 17, 1992

ELAN JOINT VENTURE WITH PARKE DAVIS

July 17, 1992

WRISTON, CARY JOIN CYGNUS BOARD

July 17, 1992

CENTOCOR FINDS IN LILLY A WHITE KNIGHT

July 17, 1992

GROWTH FACTOR TREATMENT FOR RETINAL DISORDER

July 16, 1992

CHEVRON TO SELL ECOGEN BIOPESTICIDE

July 16, 1992

ENZON PACT WITH CYTOCLONAL FOR TNF

July 16, 1992

GENENTECH BOOSTS STAKE IN XENOVA

July 16, 1992

COLLAGEN GETS RIGHTS TO HUMAN COLLAGEN

July 16, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...